The Addition of Nab-paclitaxel (Abraxane) to First Line Treatment of Metastasized Oesophagogastric Carcinoma (ACTION)

Conditions:   Esophageal Cancer;   Toxicity
Intervention:   Drug: Nab-paclitaxel
Sponsors:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA);   Celgene Corporation
Recruiting - verified July 2016

from #MedicinebyAlexandrosSfakianakis via xlomafota13 on Inoreader http://ift.tt/2au2svV
via IFTTT